- Home
- NXPL vs MBRX Comparison
NXPL vs MBRX Comparison
Compare NXPL & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXPL
- MBRX
- Stock Information
- Founded
- NXPL 1997
- MBRX 2015
- Country
- NXPL United States
- MBRX United States
- Employees
- NXPL N/A
- MBRX N/A
- Industry
- NXPL Telecommunications Equipment
- MBRX Biotechnology: Pharmaceutical Preparations
- Sector
- NXPL Telecommunications
- MBRX Health Care
- Exchange
- NXPL Nasdaq
- MBRX Nasdaq
- Market Cap
- NXPL 13.8M
- MBRX 14.7M
- IPO Year
- NXPL N/A
- MBRX 2016
- Fundamental
- Price
- NXPL $0.59
- MBRX $0.93
- Analyst Decision
- NXPL
- MBRX Strong Buy
- Analyst Count
- NXPL 0
- MBRX 2
- Target Price
- NXPL N/A
- MBRX $6.00
- AVG Volume (30 Days)
- NXPL 126.5K
- MBRX 396.2K
- Earning Date
- NXPL 05-15-2025
- MBRX 05-13-2025
- Dividend Yield
- NXPL N/A
- MBRX N/A
- EPS Growth
- NXPL N/A
- MBRX N/A
- EPS
- NXPL N/A
- MBRX N/A
- Revenue
- NXPL $65,483,000.00
- MBRX N/A
- Revenue This Year
- NXPL N/A
- MBRX N/A
- Revenue Next Year
- NXPL N/A
- MBRX N/A
- P/E Ratio
- NXPL N/A
- MBRX N/A
- Revenue Growth
- NXPL 73.44
- MBRX N/A
- 52 Week Low
- NXPL $0.43
- MBRX $0.40
- 52 Week High
- NXPL $2.30
- MBRX $5.29
- Technical
- Relative Strength Index (RSI)
- NXPL 46.74
- MBRX 46.30
- Support Level
- NXPL $0.50
- MBRX $1.00
- Resistance Level
- NXPL $0.60
- MBRX $1.14
- Average True Range (ATR)
- NXPL 0.05
- MBRX 0.07
- MACD
- NXPL 0.02
- MBRX 0.00
- Stochastic Oscillator
- NXPL 44.32
- MBRX 17.62
About NXPL NextPlat Corp
NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.